PI
ABBV icon

PGGM Investments’s AbbVie ABBV Stock Holding History

PGGM Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60,878
Closed -$12.8M – 70
2025
Q1 		$12.8M Sell
60,878
-4,106
-6% -$798K 0.17% 116
2024
Q4 		$11.5M Sell
64,984
-6,757
-9% -$1.24M 0.15% 118
2024
Q3 		$14.2M Buy
71,741
+38,951
+119% +$7.27M 0.18% 101
2024
Q2 		$5.62M Buy
32,790
+24,756
+308% +$4.1M 0.08% 169
2024
Q1 		$1.46M Sell
8,034
-3,777
-32% -$651K 0.02% 283
2023
Q4 		$1.83M Buy
+11,811
New +$1.72M 0.03% 273
2023
Q1 		– Sell
-35,688
Closed -$5.77M – 388
2022
Q4 		$5.77M Buy
35,688
+1,212
+4% +$186K 0.1% 178
2022
Q3 		$4.63M Buy
+34,476
New +$4.95M 0.08% 212
2022
Q1 		$97.6M Hold
720,906
– – 0.49% 39
2021
Q4 		$97.6M Sell
720,906
-78,340
-10% -$9.25M 0.49% 39
2021
Q3 		$86.2M Buy
799,246
+181,467
+29% +$20.7M 0.44% 50
2021
Q2 		$69.6M Buy
617,779
+111,572
+22% +$12.6M 0.3% 67
2021
Q1 		$54.8M Sell
506,207
-42,753
-8% -$4.57M 0.24% 93
2020
Q4 		$58.8M Sell
548,960
-956,680
-64% -$91.9M 0.27% 79
2020
Q3 		$132M Buy
1,505,640
+337,470
+29% +$31.8M 0.69% 45
2020
Q2 		$115M Buy
1,168,170
+14,791
+1% +$1.3M 0.66% 46
2020
Q1 		$87.9M Sell
1,153,379
-11,689
-1% -$996K 0.63% 51
2019
Q4 		$103M Hold
1,165,068
– – 0.58% 53
2019
Q3 		$88.2M Buy
1,165,068
+1,115,068
+2,230% +$76.4M 0.42% 71
2019
Q2 		$3.64M Buy
+50,000
New +$3.93M 0.02% 232
2017
Q4 		– Sell
-1,391,093
Closed -$124M – 291
2017
Q3 		$124M Buy
1,391,093
+371,459
+36% +$28.3M 0.61% 40
2017
Q2 		$73.9M Sell
1,019,634
-13,499
-1% -$908K 0.38% 63
2017
Q1 		$67.3M Sell
1,033,133
-64,890
-6% -$4.08M 0.35% 67
2016
Q4 		$68.8M Sell
1,098,023
-44,673
-4% -$2.73M 0.35% 62
2016
Q3 		$72.1M Buy
+1,142,696
New +$74M 0.36% 60

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PGGM Investments's ABBV Position: Q2 2025 in Review

PGGM Investments sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 60,878 shares — an estimated $12.8M sold.

PGGM Investments first reported a position in ABBV in Q3 2016 and held it in 25 quarters. The position peaked at $132M in Q3 2020. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • PGGM Investments reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • PGGM Investments sold 60,878 AbbVie shares in Q2 2025, an estimated $12.8M.
  • PGGM Investments first reported a position in AbbVie in Q3 2016 and held it in 25 quarters.
  • PGGM Investments's AbbVie position peaked at $132M in Q3 2020.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on PGGM Investments's 13F filing for Q2 2025, filed 18 Jul 2025.